BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10845553)

  • 1. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
    Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Cox J; Krammer B; Gatter KC; Harris AL
    Clin Exp Metastasis; 1999; 17(7):545-54. PubMed ID: 10845553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
    Kojima H; Shijubo N; Abe S
    Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
    Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC
    Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
    Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of angiogenesis in non-small cell lung cancer.
    Giatromanolaki A
    Anticancer Res; 2001; 21(6B):4373-82. PubMed ID: 11908693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer.
    Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Whitehouse RM; Talbot DC; Gatter KC; Harris AL
    Int J Cancer; 1997 Dec; 74(6):565-70. PubMed ID: 9421349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.
    Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Comley M; Whitehouse RM; Talbot DC; Gatter KC; Harris AL
    Br J Cancer; 1997; 75(4):477-81. PubMed ID: 9052396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma.
    Li Z; Shimada Y; Uchida S; Maeda M; Kawabe A; Mori A; Itami A; Kano M; Watanabe G; Imamura M
    Int J Oncol; 2000 Sep; 17(3):453-60. PubMed ID: 10938383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
    Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
    Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; O'Byrne K; Gatter KC; Harris AL
    J Pathol; 2000 Oct; 192(2):140-9. PubMed ID: 11004689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
    Bremnes RM; Camps C; Sirera R
    Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
    Relf M; LeJeune S; Scott PA; Fox S; Smith K; Leek R; Moghaddam A; Whitehouse R; Bicknell R; Harris AL
    Cancer Res; 1997 Mar; 57(5):963-9. PubMed ID: 9041202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.
    Giatromanolaki A; Koukourakis MI; Sivridis E; O'Byrne K; Cox G; Thorpe PE; Gatter KC; Harris AL
    Clin Cancer Res; 2000 May; 6(5):1917-21. PubMed ID: 10815916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
    Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
    Fontanini G; Vignati S; Lucchi M; Mussi A; Calcinai A; Boldrini L; Chiné S; Silvestri V; Angeletti CA; Basolo F; Bevilacqua G
    Br J Cancer; 1997; 75(9):1295-301. PubMed ID: 9155049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.